Kappac Pharma Financials

BSE: 506938

₹112.85

₹-5.90 (-4.97%)

As on 06-Jan-2015IST

Market cap

₹341 Cr

Revenue (TTM)

₹0 Cr

P/E Ratio

--

P/B Ratio

9

Div. Yield

0 %

Annual
Quarterly

Income Statement (₹ Cr)	TTM	Mar-14	Mar-13	Mar-12	Mar-11	Mar-10	Mar-09	Mar-08	Mar-07	Mar-06	Mar-05
Operating Revenue	--	--	--	--	--	--
Total Income	-2.17	--	--	--	--	--
Total Expenditure	0.03	0.08	0.08	0.06	0.05	0.01
EBITDA	-0.03	-0.08	-0.08	-0.06	-0.05	-0.01
Depreciation	--	--	--	--	--	--
EBIT	-0.03	-0.08	-0.08	-0.06	-0.05	-0.01
Interest	--	0.00	0.00	0.00	0.00	0.00
Other Income	-2.17	--	--	--	--	--
Exceptional Items	--	--	--	--	--	--
Profit before Tax	-2.20	-0.08	-0.08	-0.06	-0.05	-0.01
Provision for Tax	--	--	--	--	--	0.00
Profit after Tax	-2.20	-0.08	-0.08	-0.06	-0.05	-0.01

Liabilities (₹ Cr)	TTM	Mar-14	Mar-13	Mar-12	Mar-11	Mar-10	Mar-09	Mar-08	Mar-07	Mar-06	Mar-05
Shareholder's Funds	34.10	38.11	23.90	23.98	24.04	16.67
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	--	--	--	--	0.14
Current Liabilities	0.07	0.50	0.35	3.07	0.02	0.56
Total Liabilities	34.17	38.61	24.25	27.05	24.06	17.37

Assets (₹ Cr)	TTM	Mar-14	Mar-13	Mar-12	Mar-11	Mar-10	Mar-09	Mar-08	Mar-07	Mar-06	Mar-05
Non-Current Assets	14.02	8.31	8.35	23.99	24.02	4.44
Current Assets	20.15	30.30	15.90	3.06	0.04	12.92
Total Assets	34.17	38.61	24.25	27.05	24.06	17.37
Total Debt*	--	0.49	--	3.05	--	0.14
Net Current Assets	20.08	29.80	15.55	-0.01	0.02	12.36
Contingent Liabilities	--	--	--	--	--	--

Cashflow (₹ Cr)	TTM	Mar-14	Mar-13	Mar-12	Mar-11	Mar-10	Mar-09	Mar-08	Mar-07	Mar-06	Mar-05
Cash From Operating Activities	--	4.19	-4.36	-0.07	-0.67	-16.80
Cash Flow from Investing Activities	--	--	-5.42	-3.02	-6.62	--
Cash from Financing Activities	--	-4.24	9.82	3.09	7.29	16.82
Net Cash Inflow / Outflow	--	-0.04	0.03	0.00	0.01	0.02

Financials Ratios	TTM	Mar-14	Mar-13	Mar-12	Mar-11	Mar-10	Mar-09	Mar-08	Mar-07	Mar-06	Mar-05
Adjusted EPS (₹)	-0.73	-0.03	-0.04	-0.03	-0.02	-0.17
Cash EPS (₹)	--	-0.03	-0.04	-0.03	-0.02	-0.17
Adjusted Book Value (₹)	--	12.59	10.05	10.09	10.12	12.50
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	--	1.39	-1.83	-0.03	-0.28	-218.86
Free Cash Flow per Share (₹)	--	1.39	-4.12	-1.30	-0.28	-218.86

Profitability Ratios	TTM	Mar-14	Mar-13	Mar-12	Mar-11	Mar-10	Mar-09	Mar-08	Mar-07	Mar-06	Mar-05
ROCE (%)	--	-0.27	-0.33	-0.24	-0.26	-0.16
ROE (%)	-6.25	-0.27	-0.35	-0.26	-0.42	-2.79
ROA (%)	-6.23	-0.26	-0.32	-0.24	-0.25	-0.15
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	101.15	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Mar-14	Mar-13	Mar-12	Mar-11	Mar-10	Mar-09	Mar-08	Mar-07	Mar-06	Mar-05
Revenue Growth (%)	--	--	--	--	--	-100.00
EBIT Growth (%)	-56.25	-0.28	-35.39	-16.76	-293.66	-3,268.55
Net Profit Growth (%)	-13,637.50	0.08	-35.73	-16.84	-293.20	-3,635.88
EPS Growth (%)	-13,867.31	21.43	-35.69	-16.72	87.29	-3,636.52
Book Value Growth (%)	--	59.47	-0.35	-0.26	2,405.22	43,900.81

Valuation Ratios	TTM	Mar-14	Mar-13	Mar-12	Mar-11	Mar-10	Mar-09	Mar-08	Mar-07	Mar-06	Mar-05
Price / Earnings	--	--	--	--	--	--
Price / Book Value	8.97	54.69	5.61	1.65	3.32	3.57
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-155.63	--	-1,617.74	-695.60	-1,519.86	-264.69
Close Price (₹)	--	688.70	56.45	16.65	33.55	44.60
High Price (₹)	--	734.75	56.45	36.65	75.30	44.60
Low Price (₹)	--	57.55	11.00	15.35	21.10	6.95
Market Cap (₹ Cr)	341.47	--	--	--	--	--

Solvency Ratios	TTM	Mar-14	Mar-13	Mar-12	Mar-11	Mar-10	Mar-09	Mar-08	Mar-07	Mar-06	Mar-05
Debt to Equity	--	0.01	--	0.13	--	0.14
Short term debt to equity ratio	--	0.01	--	0.13	--	--
Current Ratio	287.81	60.78	45.38	1.00	1.81	23.06
Quick Ratio	287.81	60.78	45.38	1.00	3.17	23.06
Interest Coverage	--	-3,866.11	-260.17	-752.16	-1,664.71	-4,757.36

Operating Efficiency Ratios	TTM	Mar-14	Mar-13	Mar-12	Mar-11	Mar-10	Mar-09	Mar-08	Mar-07	Mar-06	Mar-05
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.